| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 2.32 MB | Adobe PDF |
Orientador(es)
Resumo(s)
The synthesis and antimicrobial activity of new spiro-β-lactams is reported. The design of the new molecules was based on the structural modulation of two previously identified lead spiro-penicillanates with dual activity against HIV and Plasmodium. The spiro-β-lactams synthesized were assayed for their in vitro activity against HIV-1, providing relevant structure-activity relationship information. Among the tested compounds, two spirocyclopentenyl-β-lactams were identified as having remarkable nanomolar activity against HIV-1. Additionally, the same molecules showed promising antiplasmodial activity, inhibiting both the hepatic and blood stages of Plasmodium infection.
Descrição
© 2021 Elsevier Masson SAS. All rights reserved.
Palavras-chave
3-Dipolar cycloaddition 2-Butynoates Allenes Anti-HIV agents Antiplasmodial agents Phosphane-catalyzed [3+2] annulations Spiro-3H-pyrazole-β-lactams Spiro-penicillanates Spirocyclic compounds Spirocyclopentenyl-β-lactams β-Lactams
Contexto Educativo
Citação
Eur J Med Chem. 2021 Jul 5;219:113439
Editora
Elsevier
